A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 83-90

  Popa, Daniela ^a   Cerdan, Julie ^a   Repérant, Christelle ^a   Guiard, Bruno P ^a   Guilloux, Jean Philippe ^a   David, Denis J ^a   Gardier, Alain M ^a  

^a University of Paris XI   (France)

Author keywords

Anxiety; Awake mice; Depression; Novelty suppressed feeding test; Open field; Repeated intracerebral microdialysis; Serotonin selective reuptake inhibitor SSRI; Tail suspension test

Indexed keywords

FLUOXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTIONALITY; HIPPOCAMPUS; IN VIVO STUDY; INTERNALIZATION; LONG TERM CARE; LONGITUDINAL STUDY; MALE; MICRODIALYSIS; MOUSE; NERVE PROJECTION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAPHE NUCLEUS; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; TRANQUILIZING ACTIVITY;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSIVE DISORDER; EMOTIONS; EXTRACELLULAR SPACE; FLUOXETINE; LONGITUDINAL STUDIES; MALE; MICE; MICE, INBRED BALB C; MICRODIALYSIS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; TIME FACTORS;

EID: 73649115601     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.037     Document Type: Article

References (59)

1. Alexandre C., Popa D., Fabre V., Bouali S., Venault P., Lesch K.P., Hamon M., and Adrien J. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 26 (2006) 5554-5564
2. Artigas F., Perez V., and Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51 (1994) 248-251
3. Artigas F., Adell A., and Celada P. Pindolol augmentation of antidepressant response. Curr. Drug Targets 7 (2006) 139-147
4. Aznavour N., Rbah L., Riad M., Reilhac A., Costes N., Descarries L., and Zimmer L. A PET imaging study of 5-HT, 1A. Receptors in cat brain after acute and chronic fluoxetine treatment. Neuroimage 33 (2006) 834-842
5. Barr L.C., Heninger G.R., Goodman W., Charney D.S., and Price L.H. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol. Psychiatry 41 (1997) 949-954
6. Belzung C., and Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125 (2001) 141-149
7. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., and Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J. Neurosci. 22 (2002) 6766-6772
8. Bert L., Favale D., Jego G., Greve P., Guilloux J.P., Guiard B.P., Gardier A.M., Suaud-Chagny M.F., and Lestage P. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. J. Neurosci. Methods 140 (2004) 53-57
9. Bill D.J., Knight M., Forster E.A., and Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br. J. Pharmacol. 103 (1991) 1857-1864
10. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur. Neuropsychopharmacol. 13 (2003) 57-66
11. Blier P., and de Montigny C. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1 (1987) 470-480
12. Blier P., and de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 (1994) 220-226
13. Blier P., and Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression?. Biol. Psychiatry 53 (2003) 193-203
14. Bouwknecht J.A., and Paylor R. Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behav. Brain Res. 136 (2002) 489-501
15. Caccia S., Fracasso C., Garattini S., Guiso G., and Sarati S. Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology 31 (1992) 343-347
16. Chaput Y., de Montigny C., and Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 333 (1986) 342-348
17. Chaput Y., de Montigny C., and Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5 (1991) 219-229
18. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., Drew M., Craig D.A., Guiard B.P., Guilloux J.P., Artymyshyn R.P., Gardier A.M., Gerald C., Antonijevic I.A., Leonardo E.D., and Hen R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62 (2009) 479-493
19. De-Miguel F.F., and Trueta C. Synaptic and extrasynaptic secretion of serotonin. Cell. Mol. Neurobiol. 25 (2005) 297-312
20. Dulawa S.C., Holick K.A., Gundersen B., and Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29 (2004) 1321-1330
21. Duman R.S., Nakagawa S., and Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (2001) 836-844
22. Durand M., Berton O., Aguerre S., Edno L., Combourieu I., Mormede P., and Chaouloff F. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats. Neuropharmacology 38 (1999) 893-907
23. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66 (2000) 65-72
24. Gardier A.M., David D.J., Jego G., Przybylski C., Jacquot C., Durier S., Gruwez B., Douvier E., Beauverie P., Poisson N., Hen R., and Bourin M. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. J. Neurochem. 86 (2003) 13-24
25. Gelfin Y., Gorfine M., and Lerer B. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am. J. Psychiatry 155 (1998) 290-292
26. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65 (1995) 319-395
27. Guilloux J.P., David D.J., Guiard B.P., Chenu F., Reperant C., Toth M., Bourin M., and Gardier A.M. Blockade of 5-HT1A receptors by,+/- -pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology 31 (2006) 2162-2172
28. Gundlah C., Hjorth S., and Auerbach S.B. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36 (1997) 475-482
29. Haddjeri N., Blier P., and de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J. Neurosci. 18 (1998) 10150-10156
30. Hajos-Korcsok E., McTavish S.F., and Sharp T. Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. Eur. J. Pharmacol. 407 (2000) 101-107
31. Hensler J.G. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26 (2002) 565-573
32. Hirano K., Kimura R., Sugimoto Y., Yamada J., Uchida S., Kato Y., Hashimoto H., and Yamada S. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br. J. Pharmacol. 144 (2005) 695-702
33. Hjorth S., and Auerbach S.B. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33 (1994) 331-334
34. Hjorth S., and Auerbach S.B. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor. Brain Res. 835 (1999) 224-228
35. Hoff P., Young W., Bloom F., Belichenko P., and Celio M. Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains (2000), Elsevier, San Diego, CA
36. Holick K.A., Lee D.C., Hen R., and Dulawa S.C. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33 (2008) 406-417
37. Hrdina P.D. Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants. Eur. J. Pharmacol. 138 (1987) 159-168
38. Invernizzi R.W. Role of TPH-2 in brain function: news from behavioral and pharmacologic studies. J. Neurosci. Res. 85 (2007) 3030-3035
39. Jolas T., Haj-Dahmane S., Kidd E.J., Langlois X., Lanfumey L., Fattaccini C.M., Vantalon V., Laporte A.M., Adrien J., Gozlan H., et al. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J. Pharmacol. Exp. Ther. 268 (1994) 1432-1443
40. Keck M.E., Sartori S.B., Welt T., Muller M.B., Ohl F., Holsboer F., Landgraf R., and Singewald N. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J. Neurochem. 92 (2005) 1170-1179
41. Kim S., Lee S., Ryu S., Suk J., and Park C. Comparative analysis of the anxiety-related behaviors in four inbred mice. Behav. Processes 60 (2002) 181-190
42. Kobayashi K., Ikeda Y., Haneda E., and Suzuki H. Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. J. Neurosci. 28 (2008) 6272-6280
43. Kreiss D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274 (1995) 866-876
44. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., Hamon M., and Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
45. Malagie I., Deslandes A., and Gardier A.M. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur. J. Pharmacol. 403 (2000) 55-65
46. Malagie I., Trillat A.C., Bourin M., Jacquot C., Hen R., and Gardier A.M. 5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J. Neurochem. 76 (2001) 865-871
47. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110 (2006) 135-370
48. Moser P.C., and Sanger D.J. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. Eur. J. Pharmacol. 372 (1999) 127-134
49. Nakayama K., Katsu H., Ando T., and Nakajo R. Possible alteration of tryptophan metabolism following repeated administration of sertraline in the rat brain. Brain Res. Bull. 59 (2003) 293-297
50. Pineyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51 (1999) 533-591
51. Popa D., Lena C., Alexandre C., and Adrien J. Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J. Neurosci. 28 (2008) 3546-3554
52. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 463 (2003) 3-33
53. Redrobe J.P., MacSweeney C.P., and Bourin M. The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur. J. Pharmacol. 318 (1996) 213-220
54. Riad M., Rbah L., Verdurand M., Aznavour N., Zimmer L., and Descarries L. Unchanged density of 5-HT, 1A. autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience 151 (2008) 692-700
55. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
56. Smith T.D., Kuczenski R., George-Friedman K., Malley J.D., and Foote S.L. In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration. Synapse 38 (2000) 460-470
57. Steru L., Chermat R., Thierry B., Mico J.A., Lenegre A., Steru M., Simon P., and Porsolt R.D. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 11 (1987) 659-671
58. Toth M. 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463 (2003) 177-184
59. Wegener G., Bandpey Z., Heiberg I.L., Mork A., and Rosenberg R. Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacology, Berl. 166 (2003) 188-194